Now that the third quarter has not yet ended, there is some uncertainty what the quarterly figures for the different regions will be.
The development will depend on how orders are placed, so it is still too early to draw conclusions, Falck told Friday Swedish news wire Nyhetsbyran SIX.
Q-Med said today its revenue in July and August 2009 was lower than in the same period a year earlier. If revenue continues to decline at the same pace for the rest of the quarter, the total revenue for the third quarter will drop 20% year-on-year, which would correspond to SEK245m.
The profit warning was prompted by the weak economic climate, CFO Alexander Kotsinas told Swedish news wire Nyhetsbyran Direkt.
The development in the summer implies a third-quarter operating profit of SEK40m, corresponding to a margin around 16%.
By mid-September, there have been no signs of a turnaround.
"We think that the market expectations are a little bit higher than how we estimate it will be," Kotsinas said.
The company will not take any immediate measures to counteract the low sales.
In the second quarter of 2009, Q-Med's revenue rose to SEK382m, up from SEK341m a year earlier. Currency effects boosted the revenue by SEK47m in April to June 2009. The second-quarter operating margin was 22%, excluding one-off effects.
The positive currency effect has, according to Kotsinas, subsided in the third quarter, which partly explains the revenue decline. However, currency effects should still be positive in July to September, according to him.
(EUR1 = SEK10.1)
Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index